Morgan Stanley’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.16M | Buy |
|
|||||
|
2025
Q1 | $823K | Sell |
|
|||||
|
2024
Q4 | $7.2M | Buy |
|
|||||
|
2024
Q3 | $1.25M | Sell |
|
|||||
|
2024
Q2 | $7.66M | Buy |
|
|||||
|
2024
Q1 | $10.9M | Sell |
|
|||||
|
2023
Q4 | $16.5M | Buy |
|
|||||
|
2023
Q3 | $4.05M | Sell |
|
|||||
|
2023
Q2 | $3.64M | Sell |
|
|||||
|
2023
Q1 | $3.31M | Sell |
|
|||||
|
2022
Q4 | $8.54M | Sell |
|
|||||
|
2022
Q3 | $9.71M | Buy |
|
|||||
|
2022
Q2 | $5.78M | Buy |
|
|||||
|
2022
Q1 | $26.2M | Buy |
|
|||||
|
2021
Q4 | $1.58M | Buy |
|
|||||
|
2021
Q3 | $2.4M | Buy |
|
|||||
|
2021
Q2 | $757K | Buy |
|
|||||
|
2021
Q1 | $799K | Sell |
|
|||||
|
2020
Q4 | $1.16M | Buy |
|
|||||
|
2020
Q3 | $251K | Sell |
|
|||||
|
2020
Q2 | $751K | Buy |
|
|||||
|
2020
Q1 | $348K | Buy |
|
|||||
|
2019
Q4 | $226K | Buy |
|
|||||
|
2019
Q3 | $23K | Buy |
|